193 related articles for article (PubMed ID: 35549502)
1. Accuracy of the 'CUT' Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study.
Shihabi AN; Hussein M; Toraih EA; Attia AS; Youssef MR; Elnahla A; Omar M; Shama M; Corsetti R; Kandil E
Cancer Invest; 2022 Sep; 40(8):693-699. PubMed ID: 35549502
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
Hong HS; Lee JY
AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
[No Abstract] [Full Text] [Related]
3. Improving Malignancy Prediction in AUS/FLUS Pediatric Thyroid Nodules with the Aid of Ultrasound.
Arora S; Khoury J; Trout AT; Chuang J
Horm Res Paediatr; 2020; 93(4):239-244. PubMed ID: 32894855
[TBL] [Abstract][Full Text] [Related]
4. Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment?
Ianni F; Pascucci D; Paragliola RM; Rota CA; Perotti G; Fadda G; Pontecorvi A; Corsello SM
Thyroid; 2020 Jan; 30(1):65-71. PubMed ID: 31552809
[No Abstract] [Full Text] [Related]
5. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
7. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
8. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
Suh YJ; Choi YJ
Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
10. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
11. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
12. Examining the Bethesda criteria risk stratification of thyroid nodules.
Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.
Gao LY; Wang Y; Jiang YX; Yang X; Liu RY; Xi XH; Zhu SL; Zhao RN; Lai XJ; Zhang XY; Zhang B
Medicine (Baltimore); 2017 Apr; 96(16):e6564. PubMed ID: 28422844
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of thyroid nodules using heterogeneity quantification software on ultrasound images: correlation with the Bethesda system and surgical pathology.
Ryu YJ; Kim JW; Park SC; Hur YH; Kim HJ; Kim TH
Sci Rep; 2024 May; 14(1):10288. PubMed ID: 38704392
[TBL] [Abstract][Full Text] [Related]
15. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
[TBL] [Abstract][Full Text] [Related]
16. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
[TBL] [Abstract][Full Text] [Related]
17. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
18. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
19. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
20. Validating the 'CUT score' risk stratification tool for indeterminate thyroid nodules using the Bethesda system for reporting thyroid cytopathology.
Pinhas S; Tessler I; Bizer LP; Khalilia K; Warman M; Adi M; Halperin D; Cohen O
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):383-390. PubMed ID: 33844064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
